Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Short coiled-coil protein pseudogene 1 (SCOCP1) is classified as a pseudogene in the human genome. Pseudogenes are genomic sequences similar to known genes but are typically non-functional due to mutations; they do not encode functional proteins. SCOCP1 does not have any known protein product, biological function, or clinical relevance as a drug target. No evidence links it to disease mechanisms or therapeutic intervention. It is not recognized as a target in pharmacology, signalling, or disease pathways. Pseudogenes like SCOCP1 are broadly considered non-functional genetic relics, although a minority of pseudogenes can have regulatory effects on their parental genes or participate in disease pathways. However, there is no evidence that SCOCP1 falls into this category—it is simply listed as a noncoding pseudogene with no associated protein, function, or role as a biomarker, drug target, or safety concern. Summary: SCOCP1 (short coiled-coil protein pseudogene 1) is a pseudogene with no established functional protein, target activity, or known biological or therapeutic significance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Short coiled-coil protein pseudogene 1 (SCOCP1).